Unknown

Dataset Information

0

Sarcorucinine-D Inhibits Cholinesterases and Calcium Channels: Molecular Dynamics Simulation and In Vitro Mechanistic Investigations.


ABSTRACT: Acetylcholinesterase (AChE) inhibitors and calcium channel blockers are considered effective therapies for Alzheimer's disease. AChE plays an essential role in the nervous system by catalyzing the hydrolysis of the neurotransmitter acetylcholine. In this study, the inhibition of the enzyme AChE by Sarcorucinine-D, a pregnane type steroidal alkaloid, was investigated with experimental enzyme kinetics and molecular dynamics (MD) simulation techniques. Kinetics studies showed that Sarcorucinine-D inhibits two cholinesterases-AChE and butyrylcholinesterase (BChE)-noncompetitively, with Ki values of 103.3 and 4.66 µM, respectively. In silico ligand-protein docking and MD simulation studies conducted on AChE predicted that Sarcorucinine-D interacted via hydrophobic interactions and hydrogen bonds with the residues of the active-site gorge of AChE. Sarcorucinine-D was able to relax contractility concentration-dependently in the intestinal smooth muscles of jejunum obtained from rabbits. Not only was the spontaneous spasmogenicity inhibited, but it also suppressed K+-mediated spasmogenicity, indicating an effect via the inhibition of voltage-dependent Ca2+ channels. Sarcorucinine-D could be considered a potential lead molecule based on its properties as a noncompetitive AChE inhibitor and a Ca2+ channel blocker.

SUBMITTER: Khalid A 

PROVIDER: S-EPMC9182202 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sarcorucinine-D Inhibits Cholinesterases and Calcium Channels: Molecular Dynamics Simulation and In Vitro Mechanistic Investigations.

Khalid Asaad A   Abdalla Mohnad M   Saeed Maria M   Ghayur Muhammad Nabeel MN   Kalauni Surya Kant SK   Albratty Mohammed M   Alhazmi Hassan A HA   Mesaik Mohammed Ahmed MA   Gilani Anwarul Hassan AH   Ul-Haq Zaheer Z  

Molecules (Basel, Switzerland) 20220524 11


Acetylcholinesterase (AChE) inhibitors and calcium channel blockers are considered effective therapies for Alzheimer's disease. AChE plays an essential role in the nervous system by catalyzing the hydrolysis of the neurotransmitter acetylcholine. In this study, the inhibition of the enzyme AChE by Sarcorucinine-D, a pregnane type steroidal alkaloid, was investigated with experimental enzyme kinetics and molecular dynamics (MD) simulation techniques. Kinetics studies showed that Sarcorucinine-D i  ...[more]

Similar Datasets

| S-EPMC4375533 | biostudies-literature
| S-EPMC4736832 | biostudies-literature
| S-EPMC3661405 | biostudies-literature
| S-EPMC8118199 | biostudies-literature
| S-EPMC7699898 | biostudies-literature
| S-EPMC10510737 | biostudies-literature
| S-EPMC4859532 | biostudies-literature
| S-EPMC11660221 | biostudies-literature
| S-EPMC2856166 | biostudies-literature
| S-EPMC4812290 | biostudies-literature